ARFID, or Avoidant/Restrictive Food Intake Disorder, is an eating disorder in which a person consistently fails to eat enough food to meet their nutritional or energy needs, but not because of concerns about body weight or appearance. Unlike anorexia or bulimia, ARFID has nothing to do with wanting to be thinner. Instead, it stems from a deep lack of interest in food, extreme sensitivity to how food looks, smells, or feels, or a fear that eating will lead to choking, vomiting, or pain.
ARFID was added to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in 2013, giving formal recognition to a condition that had long been dismissed as “extreme picky eating.” It affects children and adults alike, with prevalence estimates ranging from 0.3% to nearly 5% in general adult populations and roughly 3% to 7% in pediatric settings.
How ARFID Differs From Picky Eating
Most children go through phases of refusing vegetables or insisting on the same three meals. That kind of pickiness is developmentally normal and rarely causes health problems. ARFID crosses into disorder territory when the restricted eating leads to at least one serious consequence: significant weight loss (or failure to gain weight and grow in children), a nutritional deficiency, dependence on nutritional supplements or tube feeding, or noticeable interference with daily life, like being unable to eat at school, work, or social events.
The distinction matters because ARFID doesn’t resolve with the usual “they’ll grow out of it” approach. Without intervention, the list of accepted foods often shrinks further over time rather than expanding.
The Three Main Presentations
ARFID typically shows up in one of three patterns, though many people experience a combination.
Sensory Sensitivity
This is the presentation most people picture. Certain textures, smells, colors, or tastes trigger intense disgust or even a gag reflex. Someone with sensory-driven ARFID might eat only crunchy beige foods, for example, and find anything wet, slimy, or strongly flavored unbearable. This goes far beyond preference. The sensory reaction is involuntary and can feel as visceral as nausea.
Low Interest in Eating
Some people with ARFID simply don’t experience hunger the way most people do, or they feel full after a few bites. Eating feels like a chore rather than something enjoyable or even necessary. They may forget meals entirely or find that food just doesn’t appeal to them, regardless of what’s being served. Over time, this leads to chronically low calorie intake.
Fear of Aversive Consequences
This presentation often develops after a frightening experience with food, like a choking episode, a bout of food poisoning, or severe vomiting. The person becomes so anxious about it happening again that they start avoiding more and more foods, or eating in general. The fear can generalize well beyond the original trigger, eventually making nearly all eating stressful.
Who Gets ARFID
ARFID affects people of all ages, though it’s most commonly identified in children and adolescents. In eating disorder clinics, between 5% and 22.5% of patients meet criteria for ARFID. In specialized feeding clinics for children, that number jumps to 32% to 64%. Among the general adult population, prevalence estimates range from 0.3% to 4.8% across studies in North America, Europe, Southeast Asia, and Oceania.
There’s a strong connection between ARFID and neurodevelopmental conditions. A meta-analysis published in the International Journal of Eating Disorders found that about 16% of people with ARFID also have an autism diagnosis, a rate more than 15 times higher than in the general population. Looking at it from the other direction, roughly 11% of autistic individuals meet criteria for ARFID. The overlap makes sense: heightened sensory processing, which is common in autism, can make food textures and flavors genuinely overwhelming. ADHD and anxiety disorders also frequently co-occur with ARFID.
Physical Health Consequences
Because ARFID limits both the amount and variety of food a person eats, the nutritional fallout can be serious. Studies of people seeking treatment for ARFID have found deficiencies in vitamins D, B12, A, C, E, K, and B2, along with low levels of iron, zinc, folate, potassium, phosphate, and magnesium. Blood work often reveals low protein levels and electrolyte imbalances.
In children, the consequences compound quickly. Growth can stall or falter, bones may not develop properly due to vitamin D and calcium shortfalls, and energy levels drop. In one study of adolescents hospitalized for nutritional problems, significantly more patients with ARFID needed tube feeding compared to those with anorexia nervosa. Adults with long-standing ARFID may have low bone density, chronic fatigue, weakened immunity, and difficulty concentrating.
How ARFID Is Different From Anorexia
The single clearest distinction is body image. In anorexia nervosa, the restriction is driven by a desire to lose weight or a distorted perception of one’s body size. In ARFID, those concerns are entirely absent. A person with ARFID may actually want to gain weight or eat more but find themselves unable to. They aren’t counting calories to stay thin. They’re avoiding food because it tastes wrong, feels dangerous, or simply doesn’t register as appealing.
This distinction is built into the diagnostic criteria: ARFID cannot be diagnosed if the food restriction is better explained by anorexia or bulimia. It also can’t be diagnosed if the eating pattern is explained by a medical condition (like a gastrointestinal disease), a cultural or religious practice, or simple lack of access to food.
How ARFID Is Diagnosed
There’s no single blood test or scan for ARFID. Diagnosis relies on a clinical evaluation that considers eating behavior, nutritional status, weight history, and the impact on daily functioning. Clinicians look for at least one of the four key consequences: weight loss or poor growth, a nutritional deficiency, reliance on supplements or tube feeding, or significant disruption to social or occupational life.
Screening tools can help identify people who may have ARFID. The Nine Item ARFID Screen (NIAS) is a brief self-report questionnaire with three subscales that map onto the three presentations. Scores of 10 or above on the picky eating subscale, 9 or above on the appetite subscale, or 10 or above on the fear subscale suggest possible ARFID, particularly when the person doesn’t score high on measures of body image disturbance. A more detailed interview tool, the Pica, ARFID, and Rumination Disorder Interview (PARDI), allows clinicians to assess the full diagnostic picture.
Treatment Approaches
The most studied treatment is a specialized form of cognitive behavioral therapy called CBT-AR, designed for people ages 10 and up. It’s structured across 20 to 30 sessions in four stages.
The first stage focuses on education and stabilization. The therapist helps the person understand the disorder and establish a regular eating pattern, initially relying on foods they already accept. If the person is underweight, the early goal is to increase intake by about 500 calories per day to support gradual weight gain. For those at a stable weight, the focus shifts to introducing small variations on familiar foods or bringing back foods that were dropped over time.
The second stage involves treatment planning: reviewing what the person currently eats, identifying gaps, and choosing new foods to work on. The third stage, which takes the most sessions, targets the specific pattern driving the restriction. For sensory sensitivity, this means gradual, structured exposure to new foods, starting with simply looking at and smelling them before progressing to tasting. For fear-based ARFID, the therapist builds a hierarchy of feared foods and situations, then guides the person through gradual exposure. For low-interest ARFID, treatment includes exercises that build tolerance to feelings of fullness and bloating, alongside exposure to highly preferred foods to rebuild positive associations with eating. The final stage focuses on maintaining progress and planning for setbacks.
One Japanese study of children and adolescents with ARFID found a 77% recovery rate after inpatient treatment and outpatient follow-up averaging about 15 months. That compared favorably to a 43% recovery rate for patients with anorexia nervosa over a similar timeframe. Early identification and early intervention appear to be key factors in achieving better outcomes, particularly when the disorder begins in childhood.
Living With ARFID as an Adult
While ARFID is often discussed in the context of children, many adults live with it, sometimes without ever having received a formal diagnosis. Adults with ARFID frequently describe years of being told they’re “just picky” or need to “try harder,” which can lead to shame and social withdrawal. Eating out, attending dinner parties, traveling, or even sharing meals with a partner can feel impossible when your safe food list is short.
The social toll is one of the diagnostic criteria for a reason. Food is deeply embedded in how humans connect, celebrate, and bond. When eating is a source of anxiety or distress rather than pleasure, the ripple effects touch relationships, work, and mental health. Anxiety and depression commonly accompany ARFID in adults, sometimes making it harder to tell which came first.
Treatment for adults follows the same general principles as for younger patients, with CBT-AR being the most evidence-based option. The pace of food expansion tends to be slower in adults who have had decades of avoidant eating, but meaningful progress, including adding new foods, improving nutritional status, and reducing the social impact, is achievable.